Current state and future perspective of molecular diagnosis of fine-needle aspiration biopsy of thyroid nodules

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 7, 2011, Pages 2016-2026

  Ferraz, Carolina ^a   Eszlinger, Markus ^a   Paschke, Ralf ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; MESSENGER RNA; MICRORNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN PATCHED; PROTEIN RET; TRANSCRIPTION FACTOR PAX8; TUMOR MARKER;

ASPIRATION BIOPSY; CANCER CLASSIFICATION; CYTOCHEMISTRY; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; MICROARRAY ANALYSIS; MOLECULAR DIAGNOSIS; MOLECULAR GENETICS; MUTATIONAL ANALYSIS; ONCOGENE RAS; PRIORITY JOURNAL; REVIEW; RNA ANALYSIS; SENSITIVITY AND SPECIFICITY; SOMATIC MUTATION; STANDARDIZATION; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROID NODULE; THYROID PAPILLARY CARCINOMA;

BIOPSY, FINE-NEEDLE; HUMANS; SENSITIVITY AND SPECIFICITY; THYROID GLAND; THYROID NODULE;

EID: 79960096659     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2010-2567     Document Type: Review

References (86)

1. Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedus L, Vitti P 2010 American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract 16(Suppl 1):1-43
2. Nagataki S, Nyström E 2002 Epidemiology and primary prevention of thyroid cancer. Thyroid 12:889-896 (Pubitemid 35332993)
3. British Thyroid Association and Royal College of Physicians 2007 Guidelines for the management of thyroid cancer. London: Royal College of Physicians
4. Camargo R, Corigliano S, Friguglietti C, Gauna A, Harach R, Munizaga F, Niepomniszcze H, Pitoia F, Pretell E, Vaisman M, Ward LS, Wohllk N, Tomimori E 2009 Latin American Thyroid Society recommendations for the management of thyroid nodules. Arq Bras Endocrinol Metabol 53:1167-1175
5. Cooper DS, Doherty GM, Haugen BR, Hauger BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214
6. Carpi A, Ferrari E, Toni MG, Sagripanti A, Nicolini A, Di Coscio G 1996 Needle aspiration techniques in preoperative selection of patients with thyroid nodules: a long-term study. J Clin Oncol 14: 1704-1712 (Pubitemid 26134230)
7. Dralle H, Sekulla C, Haerting J, Timmermann W, Neumann HJ, Kruse E, Grond S, Mühlig HP, Richter C, Voss J, Thomusch O, Lippert H, Gastinger I, Brauckhoff M, Gimm O 2004 Risk factors of paralysis and functional outcome after recurrent laryngeal nerve monitoring in thyroid surgery. Surgery 136:1310-1322 (Pubitemid 39647550)
8. Rosato L, Avenia N, Bernante P, De Palma M, Gulino G, Nasi PG, Pelizzo MR, Pezzullo L 2004 Complications of thyroid surgery: analysis of a multicentric study on 14,934 patients operated on in Italy over 5 years. World J Surg 28:271-276 (Pubitemid 38375527)
9. Lewis CM, Chang KP, Pitman M, Faquin WC, Randolph GW 2009 Thyroid fine-needle aspiration biopsy: variability in reporting. Thyroid 19:717-723
10. Gharib H 1997 Changing concepts in the diagnosis and management of thyroid nodules. Endocrinol Metab Clin North Am 26:777-800 (Pubitemid 27528198)
11. Piana S, Frasoldati A, Ferrari M, Valcavi R, Froio E, Barbieri V, Pedroni C, Gardini G 6 July 2010 Is a five-category reporting scheme for thyroid fine needle aspiration cytology accurate? Experience of over 18,000 FNAs reported at the same institution during 1998-2007. Cytopathology 10.1111/j.1365-2303.2010. 00777.x
12. Bartolazzi A, Orlandi F, Saggiorato E, Volante M, Arecco F, Rossetto R, Palestini N, Ghigo E, Papotti M, Bussolati G, Martegani MP, Pantellini F, Carpi A, Giovagnoli MR, Monti S, Toscano V, Sciacchitano S, Pennelli GM, Mian C, Pelizzo MR, Rugge M, Troncone G, Palombini L, Chiappetta G, Botti G, Vecchione A, Bellocco R 2008 Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study. Lancet Oncol 9:543-549
13. de Matos PS, Ferreira AP, de Oliveira Facuri F, Assumpção LV, Metze K, Ward LS 2005 Usefulness of HBME-1, cytokeratin 19 and galectin-3 immunostaining in the diagnosis of thyroid malignancy. Histopathology 47:391-401 (Pubitemid 41428488)
14. Saggiorato E, De Pompa R, Volante M, Cappia S, Arecco F, Dei Tos AP, Orlandi F, Papotti M 2005 Characterization of thyroid 'follicular neoplasms' in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application. Endocr Relat Cancer 12:305-317
15. Takano T, Miyauchi A, Matsuzuka F, Yoshida H, Kuma K, Amino N 2003 Ubiquitous expression of galectin-3 mRNA in benign and malignant thyroid tumors. Cancer Lett 199:69-73 (Pubitemid 37088140)
16. Volante M, Bozzalla-Cassione F, DePompa R, Saggiorato E, Bartolazzi A, Orlandi F, Papotti M 2004 Galectin-3 and HBME-1 expression in oncocytic cell tumors of the thyroid. Virchows Arch 445:183-188 (Pubitemid 39215550)
17. Faggiano A, Caillou B, Lacroix L, Talbot M, Filetti S, Bidart JM, Schlumberger M 2007 Functional characterization of human thyroid tissue with immunohistochemistry. Thyroid 17:203-211 (Pubitemid 46557367)
18. Freitas BC, Cerutti JM 2010 Genetic markers differentiating follicular thyroid carcinoma from benign lesions. Mol Cell Endocrinol 321:77-85
19. Eszlinger M, Krohn K, Hauptmann S, Dralle H, Giordano TJ, Paschke R 2008 Perspectives for improved and more accurate classification of thyroid epithelial tumors. J Clin Endocrinol Metab 93: 3286-3294
20. Moses W, Weng J, Sansano I, Peng M, Khanafshar E, Ljung BM, Duh QY, Clark OH, Kebebew E 2010 Molecular testing for somatic mutations improves the accuracy of thyroid fine-needle aspiration biopsy. World J Surg 34:2589-2594
21. Eszlinger M, Paschke R 2010 Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns. Mol Cell Endocrinol 322:29-37
22. Nikiforova MN, Nikiforov YE 2009 Molecular diagnostics and predictors in thyroid cancer. Thyroid 19:1351-1361
23. Cheung CC, Carydis B, Ezzat S, Bedard YC, Asa SL 2001 Analysis of ret/PTC gene rearrangements refines the fine needle aspiration diagnosis of thyroid cancer. J Clin Endocrinol Metab 86:2187-2190
24. Chung KW, Yang SK, Lee GK, Kim EY, Kwon S, Lee SH, Park do J, Lee HS, Cho BY, Lee ES, Kim SW 2006 Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutationprevalent area. Clin Endocrinol (Oxf) 65:660-666 (Pubitemid 44583829)
25. Cohen Y, Rosenbaum E, Clark DP, Zeiger MA, Umbricht CB, Tufano RP, Sidransky D, Westra WH 2004 Mutational analysis of BRAF in fine needle aspiration biopsies of the thyroid: a potential application for the preoperative assessment of thyroid nodules. Clin Cancer Res 10:2761-2765 (Pubitemid 38509152)
26. Girlando S, Cuorvo LV, Bonzanini M, Morelli L, Amadori P, Dalla Palma P, Barbareschi M 2010 High prevalence of B-RAF mutation in papillary carcinoma of the thyroid in northeast Italy. Int J Surg Pathol 18:173-176
27. Hayashida N, Namba H, Kumagai A, Hayashi T, Ohtsuru A, Ito M, Saenko VA, Maeda S, Kanematsu T, Yamashita S 2004 A rapid and simple detection method for the BRAF(T1796A) mutation in fineneedle aspirated thyroid carcinoma cells. Thyroid 14:910-915 (Pubitemid 39612909)
28. Kim KH, Kang DW, Kim SH, Seong IO, Kang DY 2004 Mutations of the BRAF gene in papillary thyroid carcinoma in a Korean population. Yonsei Med J 45:818-821 (Pubitemid 39545368)
29. Kim SW, Lee JI, Kim JW, Ki CS, Oh YL, Choi YL, Shin JH, Kim HK, Jang HW, Chung JH 2010 BRAFV600E mutation analysis in fineneedle aspiration cytology specimens for evaluation of thyroid nodule: a large series in a BRAFV600E-prevalent population. J Clin Endocrinol Metab 95:3693-3700
30. Marchetti I, Lessi F, Mazzanti CM, Bertacca G, Elisei R, Coscio GD, Pinchera A, Bevilacqua G 2009 A morpho-molecular diagnosis of papillary thyroid carcinoma: BRAF V600E detection as an important tool in preoperative evaluation of fine-needle aspirates. Thyroid 19:837-842
31. NamSY, Han BK, Ko EY, Kang SS, Hahn SY, Hwang JY, Nam MY, Kim JW, Chung JH, Oh YL, Shin JH 2010 BRAF V600E mutation analysis of thyroid nodules needle aspirates in relation to their ultrasongraphic classification: a potential guide for selection of samples for molecular analysis. Thyroid 20:273-279
32. Pizzolanti G, Russo L, Richiusa P, Bronte V, Nuara RB, Rodolico V, Amato MC, Smeraldi L, Sisto PS, Nucera M, Bommarito A, Citarrella R, Lo Coco R, Cabibi D, Lo Coco A, Frasca F, Gulotta G, Latteri MA, Modica G, Galluzzo A, Giordano C 2007 Fine-needle aspiration molecular analysis for the diagnosis of papillary thyroid carcinoma through BRAF V600E mutation and RET/PTC rearrangement. Thyroid 17:1109-1115 (Pubitemid 350207747)
33. Rowe LR, Bentz BG, Bentz JS 2006 Utility of BRAF V600E mutation detection in cytologically indeterminate thyroid nodules. Cytojournal 3:10
34. Sapio MR, Posca D, Raggioli A, Guerra A, Marotta V, Deandrea M, Motta M, Limone PP, Troncone G, Caleo A, Rossi G, Fenzi G, Vitale M2007 Detection of RET/PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings. Clin Endocrinol (Oxf) 66:678-683
35. Xing M, Tufano RP, Tufaro AP, Basaria S, Ewertz M, Rosenbaum E, Byrne PJ, Wang J, Sidransky D, Ladenson PW 2004 Detection of BRAF mutation on fine needle aspiration biopsy specimens: a new diagnostic tool for papillary thyroid cancer. J Clin Endocrinol Metab 89:2867-2872 (Pubitemid 38766378)
36. Zatelli MC, Trasforini G, Leoni S, Frigato G, Buratto M, Tagliati F, Rossi R, Cavazzini L, Roti E, degli Uberti EC 2009 BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies. Eur J Endocrinol 161:467-473
37. Salvatore G, Giannini R, Faviana P, Caleo A, Migliaccio I, Fagin JA, Nikiforov YE, Troncone G, Palombini L, Basolo F, SantoroM2004 Analysis of BRAF point mutation and RET/PTC rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma. J Clin Endocrinol Metab 89:5175-5180
38. Musholt TJ, Fottner C, Weber MM, Eichhorn W, Pohlenz J, Musholt PB, Springer E, Schad A 2010 Detection of papillary thyroid carcinoma by analysis of BRAF and RET/PTC1 mutations in fine-needle aspiration biopsies of thyroid nodules. World J Surg 34:2595-2603
39. Cantara S, Capezzone M, Marchisotta S, Capuano S, Busonero G, Toti P, Di Santo A, Caruso G, Carli AF, Brilli L, Montanaro A, Pacini F, Montanaro A 2010 Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology. J Clin Endocrinol Metab 95: 1365-1369
40. Nikiforov YE, Steward DL, Robinson-Smith TM, Haugen BR, Klopper JP, Zhu Z, Fagin JA, Falciglia M, Weber K, Nikiforova MN 2009 Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab 94:2092-2098
41. Ohori NP, Nikiforova MN, Schoedel KE, LeBeau SO, Hodak SP, Seethala RR, Carty SE, Ogilvie JB, Yip L, Nikiforov YE 2010 Contribution of molecular testing to thyroid fine-needle aspiration cytology of "follicular lesion of undetermined significance/atypia of undetermined significance." Cancer Cytopathol 118:17-23
42. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Sherman SI, Tuttle RM 2006 Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16:109-142
43. Xing M, Clark D, Guan H, Ji M, Dackiw A, Carson KA, Kim M, Tufaro A, Ladenson P, Zeiger M, Tufano R 2009 BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer. J Clin Oncol 27:2977-2982
44. Nikiforova MN, Lynch RA, Biddinger PW, Alexander EK, Dorn 2nd GW, Tallini G, Kroll TG, Nikiforov YE 2003 RAS point mutations and PAX8-PPAR γ rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. J Clin Endocrinol Metab 88:2318-2326 (Pubitemid 36549913)
45. Esapa CT, Johnson SJ, Kendall-Taylor P, Lennard TW, Harris PE 1999 Prevalence of Ras mutations in thyroid neoplasia. Clin Endocrinol (Oxf) 50:529-535 (Pubitemid 29193238)
46. Ezzat S, Zheng L, Kolenda J, Safarian A, Freeman JL, Asa SL 1996 Prevalence of activating ras mutations in morphologically characterized thyroid nodules. Thyroid 6:409-416
47. Lemoine NR, Mayall ES, Wyllie FS, Williams ED, Goyns M, Stringer B, Wynford-Thomas D 1989 High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis. Oncogene 4:159-164 (Pubitemid 19096939)
48. Marques AR, Espadinha C, Catarino AL, Moniz S, Pereira T, Sobrinho LG, Leite V 2002 Expression of PAX8-PPAR γ1 rearrangements in both follicular thyroid carcinomas and adenomas. J Clin Endocrinol Metab 87:3947-3952
49. Nikiforova MN, Biddinger PW, Caudill CM, Kroll TG, Nikiforov YE 2002 PAX8-PPARγ rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses. Am J Surg Pathol 26:1016-1023 (Pubitemid 34810562)
50. Jin L, Sebo TJ, Nakamura N, Qian X, Oliveira A, Majerus JA, Johnson MR, Lloyd RV 2006 BRAF mutation analysis in fine needle aspiration (FNA) cytology of the thyroid. Diagn Mol Pathol 15: 136-143 (Pubitemid 44325474)
51. Castro P, Rebocho AP, Soares RJ, Magalhães J, Roque L, Trovisco V, Vieira de Castro I, Cardoso-de-Oliveira M, Fonseca E, Soares P, Sobrinho-Simões M 2006 PAX8-PPARγ rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma. J Clin Endocrinol Metab 91:213-220 (Pubitemid 43069140)
52. Kim CS, Zhu X 2009 Lessons from mouse models of thyroid cancer. Thyroid 19:1317-1331
53. Tetzlaff MT, LiVolsi V, Baloch ZW 2006 Assessing the utility of a mutational assay for B-RAF as an adjunct to conventional fine needle aspiration of the thyroid gland. Adv Anat Pathol 13:228-237 (Pubitemid 44439977)
54. Clark DP 2010 Molecular diagnostics on thyroid fine-needle aspirations: the pathway to value creation. Cancer Cytopathol 118: 14-16
55. Eszlinger M, Krohn K, Kukulska A, Jarzab B, Paschke R 2007 Perspectives and limitations of microarray-based gene expression profiling of thyroid tumors. Endocr Rev 28:322-338 (Pubitemid 46984830)
56. Aogi K, Kitahara K, Buley I, Backdahl M, Tahara H, Sugino T, Tarin D, Goodison S 1998 Telomerase activity in lesions of the thyroid: application to diagnosis of clinical samples including fineneedle aspirates. Clin Cancer Res 4:1965-1970 (Pubitemid 28369182)
57. Bernet VJ, Anderson J, Vaishnav Y, Solomon B, Adair CF, Saji M, Burman KD, Burch HB, Ringel MD 2002 Determination of galectin- 3 messenger ribonucleic acid overexpression in papillary thyroid cancer by quantitative reverse transcription-polymerase chain reaction. J Clin Endocrinol Metab 87:4792-4796 (Pubitemid 35247077)
58. Casey MB, Lohse CM, Lloyd RV 2003 Distinction between papillary thyroid hyperplasia and papillary thyroid carcinoma by immunohistochemical staining for cytokeratin 19, galectin-3, and HBME-1. Endocr Pathol 14:55-60 (Pubitemid 36605683)
59. Haugen BR, Nawaz S, Markham N, Hashizumi T, Shroyer AL, Werness B, Shroyer KR 1997 Telomerase activity in benign and malignant thyroid tumors. Thyroid 7:337-342 (Pubitemid 27295128)
60. Inohara H, Honjo Y, Yoshii T, Akahani S, Yoshida J, Hattori K, Okamoto S, Sawada T, Raz A, Kubo T 1999 Expression of galectin- 3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms. Cancer 85:2475-2484 (Pubitemid 29244859)
61. Ippolito A, Vella V, La Rosa GL, Pellegriti G, Vigneri R, Belfiore A 2001 Immunostaining for Met/HGF receptor may be useful to identify malignancies in thyroid lesions classified suspicious at fine-needle aspiration biopsy. Thyroid 11:783-787 (Pubitemid 32762718)
62. Mase T, Funahashi H, Koshikawa T, Imai T, Nara Y, Tanaka Y, Nakao A 2003 HBME-1 immunostaining in thyroid tumors especially in follicular neoplasm. Endocr J 50:173-177 (Pubitemid 36554108)
63. Raphael SJ 2002 The meanings of markers: ancillary techniques in diagnosis of thyroid neoplasia. Endocr Pathol 13:301-311 (Pubitemid 36237984)
64. Sack MJ, Astengo-Osuna C, Lin BT, Battifora H, LiVolsi VA 1997 HBME-1 immunostaining in thyroid fine-needle aspirations: a useful marker in the diagnosis of carcinoma. Mod Pathol 10:668-674 (Pubitemid 27321757)
65. Saggiorato E, Cappia S, De Giuli P, Mussa A, Pancani G, Caraci P, Angeli A, Orlandi F 2001 Galectin-3 as a presurgical immunocytodiagnostic marker of minimally invasive follicular thyroid carcinoma. J Clin Endocrinol Metab 86:5152-5158 (Pubitemid 33070230)
66. Borup R, Rossing M, Henao R, Yamamoto Y, Krogdahl A, Godballe C, Winther O, Kiss K, Christensen L, Høgdall E, Bennedbaek F, Nielsen FC 2010 Molecular signatures of thyroid follicular neoplasia. Endocr Relat Cancer 17:691-708
67. Cerutti JM, Delcelo R, Amadei MJ, Nakabashi C, Maciel RM, Peterson B, Shoemaker J, Riggins GJ 2004 A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression. J Clin Invest 113:1234-1242 (Pubitemid 38544109)
68. Eszlinger M, Wiench M, Jarzab B, Krohn K, Beck M, Läuter J, Gubała E, Fujarewicz K, Swierniak A, Paschke R 2006 Meta- and reanalysis of gene expression profiles of hot and cold thyroid nodules and papillary thyroid carcinoma for gene groups. J Clin Endocrinol Metab 91:1934-1942
69. Foukakis T, Gusnanto A, Au AY, Höög A, Lui WO, Larsson C, Wallin G, Zedenius J 2007 A PCR-based expression signature of malignancy in follicular thyroid tumors. Endocr Relat Cancer 14: 381-391 (Pubitemid 47242637)
70. Fujarewicz K, Jarzab M, Eszlinger M, Krohn K, Paschke R, Oczko- Wojciechowska M, Wiench M, Kukulska A, Jarzab B, Swierniak A 2007 A multi-gene approach to differentiate papillary thyroid carcinoma from benign lesions: gene selection using support vector machines with bootstrapping. Endocr Relat Cancer 14:809-826 (Pubitemid 350074069)
71. Jarzab B, Wiench M, Fujarewicz K, Simek K, Jarzab M, Oczko- Wojciechowska M, Wloch J, Czarniecka A, Chmielik E, Lange D, Pawlaczek A, Szpak S, Gubala E, Swierniak A 2005 Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implications. Cancer Res 65:1587-1597 (Pubitemid 40270189)
72. Kebebew E, Peng M, Reiff E, McMillan A 2006 Diagnostic and extent of disease multigene assay for malignant thyroid neoplasms. Cancer 106:2592-2597
73. Krause K, Eszlinger M, Gimm O, Karger S, Engelhardt C, Dralle H, Fuhrer D 2008 TFF3 based candidate gene discrimination of benign and malignant thyroid tumours in a region with borderline iodine deficiency. J Clin Endocrinol Metab 93:1390-1393 (Pubitemid 351519738)
74. Mazzanti C, Zeiger MA, Costouros NG, Umbricht C, Westra WH, Smith D, Somervell H, Bevilacqua G, Alexander HR, Libutti SK, Costourous N 2004 Using gene expression profiling to differentiate benign versus malignant thyroid tumors. Cancer Res 64:2898-2903 (Pubitemid 38500631)
75. Weber F, Shen L, Aldred MA, Morrison CD, Frilling A, Saji M, Schuppert F, Broelsch CE, Ringel MD, Eng C 2005 Genetic classification of benign and malignant thyroid follicular neoplasia based on a 3-gene combination. J Clin Endocrinol Metab 90:2512-2521 (Pubitemid 40686285)
76. Sapio MR, Guerra A, Posca D, Limone PP, Deandrea M, Motta M, Troncone G, Caleo A, Vallefuoco P, Rossi G, Fenzi G, Vitale M 2007 Combined analysis of galectin-3 and BRAFV600E improves the accuracy of fine-needle aspiration biopsy with cytological findings suspicious for papillary thyroid carcinoma. Endocr Relat Cancer 14:1089-1097 (Pubitemid 351252440)
77. Chudova D, Wilde JI, Wang ET, Wang H, Rabbee N, Egidio CM, Reynolds J, Tom E, Pagan M, Rigl CT, Friedman L, Wang CC, Lanman RB, Zeiger M, Kebebew E, Rosai J, Fellegara G, LiVolsi VA, Kennedy GC 2010 Molecular classification of thyroid nodules using high-dimensionality genomic data. J Clin Endocrinol Metab 95:5296-5304
78. He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S, Calin GA, Liu CG, Franssila K, Suster S, Kloos RT, Croce CM, de la Chapelle A 2005 The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci USA 102:19075-19080 (Pubitemid 43049568)
79. Pallante P, Visone R, Ferracin M, Ferraro A, Berlingieri MT, Troncone G, Chiappetta G, Liu CG, Santoro M, Negrini M, Croce CM, Fusco A 2006 MicroRNA deregulation in human thyroid papillary carcinomas. Endocr Relat Cancer 13:497-508 (Pubitemid 43886672)
80. Weber F, Teresi RE, Broelsch CE, Frilling A, Eng C 2006 A limited set of human microRNA is deregulated in follicular thyroid carcinoma. J Clin Endocrinol Metab 91:3584-3591 (Pubitemid 44402141)
81. Nikiforova MN, Tseng GC, Steward D, Diorio D, Nikiforov YE 2008 MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. J Clin Endocrinol Metab 93: 1600-1608 (Pubitemid 351656494)
82. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, LambJ, Peck D, Sweet- Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR 2005 MicroRNA expression profiles classify human cancers. Nature 435:834-838 (Pubitemid 40839735)
83. Baloch ZW, Cibas ES, Clark DP, Layfield LJ, Ljung BM, Pitman MB, Abati A 2008 The National Cancer Institute Thyroid fine needle aspiration state of the science conference: a summation. Cytojournal 5:6
84. Horvath E, Majlis S, Rossi R, Franco C, Niedmann JP, Castro A, Dominguez M 2009 An ultrasonogram reporting system for thyroid nodules stratifying cancer risk for clinical management. J Clin Endocrinol Metab 94:1748-1751
85. Nga ME, Kumarasinghe MP, Tie B, Sterrett GF, Wood B, Walsh J, Nguyen H, Whyte A, Frost FA 2010 Experience with standardized thyroid fine-needle aspiration reporting categories: follow-up data from 529 cases with "indeterminate" or "atypical" reports. Cancer Cytopathol 118:423-433
86. Oertel YC, Miyahara-Felipe L, Mendoza MG, Yu K 2007 Value of repeated fine needle aspirations of the thyroid: an analysis of over ten thousand FNAs. Thyroid 17:1061-1066 (Pubitemid 350207762)